NEW YORK and TOKYO, March 14, 2025 /PRNewswire/ — Mediagene Inc.(“the Company”), a group company of TNL Mediagene (NASDAQ: TNMG), has announced its “Brandformance Strategy” to maximize the appeal of advertisers’ products by leveraging its strong media engagement and content creative…

In recognition of Women’s History Month, our Identity + Innovation spotlight features Devi SenGupta. Hear how Devi’s background has shaped her approach to developing new medicines and to bringing Gilead closer to a cure for HIV.

Gilead Sciences

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California. 

Originally published by Gilead Sciences.

SOUTHERN PINES, N.C., March 14, 2025 /PRNewswire/ — The Board of Directors of First Bancorp (NASDAQ: FBNC) (the “Company”), the parent company of First Bank, has declared a cash dividend on its common stock of $0.22 per share payable on April 25, 2025 to shareholders of record as of…

LONDRES, 14 mars 2025 /PRNewswire/ — Storyteq, la technologie marketing exclusive de l’Inspired Thinking Group (ITG), a été nommée leader dans le rapport Magic Quadrant™ 2025 de Gartner® pour les plateformes de marketing de contenu – c’est la troisième année consécutive qu’elle est…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.